SPP1 and ischemic stroke: Application of the EPAM-ia method for concomitant isolation and analysis of NVU cells, could thus unveil novel therapies addressing BBB dysfunction in neurological diseases by targeting the whole NVU, as demonstrated by osteopontin targeting in ischemic stroke (Fig. 9a).